Literature DB >> 21613391

Comparison of exposure to selected cigarette smoke constituents in adult smokers and nonsmokers in a European, multicenter, observational study.

Dirk Lindner1, Stephen Smith, Claire Martin Leroy, Anthony R Tricker.   

Abstract

BACKGROUND: This multicenter, observational study was conducted in three European countries (Germany, Switzerland, and the United Kingdom) to determine the exposure of adult cigarette smokers and nonsmokers to selected cigarette smoke constituents: 1,3-butadiene, 2-naphthylamine, 4-aminobiphenyl, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), acrolein, benzene, carbon monoxide, nicotine, pyrene, and o-toluidine.
METHODS: Smokers were grouped by tar category (TC) according to the tar yield of their regular cigarette brand: TC1: ≤4 mg tar, TC2: 5-7 mg tar, and TC3: ≥8 mg tar [to the legal tar yield ceiling in the respective countries (10 or 12 mg tar)]. Levels of biomarkers of exposure to the aforementioned cigarette smoke constituents were compared between smokers and nonsmokers, and within smokers across tar categories.
RESULTS: The full population consisted of 1,631 subjects (1,223 smokers and 408 nonsmokers). Biomarkers of exposure were analyzed for 1,558 subjects (valid case population) as follows: 1,159 smokers (TC1: n = 402, TC2: n = 379, TC3: n = 378), and 399 nonsmokers. Exposure levels were higher in smokers than nonsmokers and increased with increasing tar yield and cigarette consumption. An association of tar category and exposure level was observed for all smoke constituents, except pyrene, 4-aminobiphenyl, and o-toluidine, whereas only NNK exposure was different in all three tar categories.
CONCLUSIONS: Smoking status and, among smokers, daily cigarette consumption and tar yield were observed to affect biomarker of exposure levels. IMPACT: This research provides a comprehensive evaluation of smoke constituent exposure of adult cigarette smokers and nonsmokers in three European countries. ©2011 AACR

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21613391     DOI: 10.1158/1055-9965.EPI-10-1186

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  7 in total

Review 1.  Scientific assessment of the use of sugars as cigarette tobacco ingredients: a review of published and other publicly available studies.

Authors:  Ewald Roemer; Matthias K Schorp; Jean-Jacques Piadé; Jeffrey I Seeman; Donald E Leyden; Hans-Juergen Haussmann
Journal:  Crit Rev Toxicol       Date:  2012-01-21       Impact factor: 5.635

2.  Short-term traffic related exposures and biomarkers of nitro-PAH exposure and oxidative DNA damage.

Authors:  Andreas M Neophytou; Jaime E Hart; Yan Chang; Junfeng Jim Zhang; Thomas J Smith; Eric Garshick; Francine Laden
Journal:  Toxics       Date:  2014-09

3.  Make your own cigarettes: toxicant exposure, smoking topography, and subjective effects.

Authors:  Bartosz Koszowski; Zachary R Rosenberry; Lauren C Viray; Jennifer L Potts; Wallace B Pickworth
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-06-12       Impact factor: 4.254

Review 4.  Identification of possible cigarette smoke constituents responsible for muscle catabolism.

Authors:  Oren Rom; Sharon Kaisari; Dror Aizenbud; Abraham Z Reznick
Journal:  J Muscle Res Cell Motil       Date:  2012-05-22       Impact factor: 2.698

5.  Urinary biomarkers of smokers' exposure to tobacco smoke constituents in tobacco products assessment: a fit for purpose approach.

Authors:  Evan O Gregg; Emmanuel Minet; Michael McEwan
Journal:  Biomarkers       Date:  2013-07-31       Impact factor: 2.658

6.  Identification and validation of a cigarette smoke-related five-gene signature as a prognostic biomarker in kidney renal clear cell carcinoma.

Authors:  Yefei Huang; Qinzhi Wang; Yu Tang; Zixuan Liu; Guixiang Sun; Zhaojun Lu; Yansu Chen
Journal:  Sci Rep       Date:  2022-02-09       Impact factor: 4.379

7.  Reduced levels of biomarkers of exposure in smokers switching to the Carbon-Heated Tobacco Product 1.0: a controlled, randomized, open-label 5-day exposure trial.

Authors:  Cam Tuan Tran; Marija Bosilkovska; Guillaume de La Bourdonnaye; Nicolas Blanc; Christelle Haziza
Journal:  Sci Rep       Date:  2020-11-05       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.